FTC Pushes For Watson CEO To Testify In Provigil Probe
The Federal Trade Commission has again urged a federal court to force the CEO of Watson Pharmaceuticals Inc. to testify about a settlement in a Cephalon Inc. patent infringement suit over...To view the full article, register now.
Already a subscriber? Click here to view full article